9259
0
Posted on Jun 03, 2005, 6 a.m.
By Bill Freeman
BusinessWeek provides insights into privately funded medical research - a busy, fascinating realm of human endeavor that the mainstream media largely ignores (most likely because reporting on it requires actual work). "Medical care is reaching a tipping point. Not that most patients will be healed right away -- the vast majority of sick people continue to dose themselves with tiny bits of chemicals, otherwise known as pills, that represent medicine's Old Guard. But the times are changing. The p
BusinessWeek provides insights into privately funded medical research - a busy, fascinating realm of human endeavor that the mainstream media largely ignores (most likely because reporting on it requires actual work). "Medical care is reaching a tipping point. Not that most patients will be healed right away -- the vast majority of sick people continue to dose themselves with tiny bits of chemicals, otherwise known as pills, that represent medicine's Old Guard. But the times are changing. The past 30 years of biological discoveries, insights into the human genome, and exotic chemical manipulation have unleashed a wave of biological drugs, many of them reengineered human proteins. These molecules have the power to change the prognoses for a huge range of diseases all but untreatable just five years ago."
Read Full Story
Read Full Story
